Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

August 31, 2008

Conditions
Diabetes MellitusUpper Respiratory Infection
Interventions
DRUG

Technosphere Insulin

Technosphere® Insulin (TI) Inhalation Powder, prandial

Trial Locations (24)

10023

M.E.R.I., New York

21204

MODEL Clinical Research, Baltimore

30035

Private Practice, Decatur

30076

Endocrine Research Solutions, Inc., Roswell

44060

Your Diabetes Endocrine Nutrition Group, Mentor

44122

Rapid Medical Research Inc, Cleveland

59101

Billings Clinic Research Division, Billings

60607

Cedar-Crosse Research Center, Chicago

63031

Healthcare Research, Florissant

78229

Diabetes & Glandular Disease Research Assoc PA, San Antonio

84044

Magna Center for Family Medicine, Magna

85712

Arizona Research Associates, Tuscon

87106

New Mexico Clinical Research & Osteoporosis Center, Albuquerque

92648

Diabetes/Lipid Management and Research Center, Huntington Beach

105229

FSI Principal Military Clinical Hospital n.a. academician N.N. Burdenko of the Ministry of Defense, Moscow

113093

Russian State Medical University City Hospital # 4, Moscow

125315

RAAMS Endocrinology and Diabetology Department, Moscow

150003

Clinical Pharm Dept of Yaroslavl Clin Hospital, Yaroslavl

150062

NHI Yaroslavl Regional Clinical Hospital, Yaroslavl

Yaroslavl Regional Clinical Hospital, Yaroslavl

650061

Kemerovo State Medical Academy of Ministry of Health, Kemerovo

NHI Kemerovo Regional Clinical Hospital, Kemerovo

Unknown

Valley Research (Norwood), Fresno

N6C 5J1

Parkwood Hospital, London

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY